Journal article

Renal denervation in combination with angiotensin receptor blockade prolongs blood pressure trough during hemorrhage

RR Singh, Z McArdle, LC Booth, CN May, GA Head, KM Moritz, MP Schlaich, KM Denton

Hypertension | Published : 2022

Abstract

Majority of patients with hypertension and chronic kidney disease (CKD) undergoing renal denervation (RDN) are maintained on antihypertensive medication. However, RDN may impair compensatory responses to hypotension induced by blood loss. Therefore, continuation of antihypertensive medications in denervated patients may exacerbate hypotensive episodes. This study examined whether antihypertensive medication compromised hemodynamic responses to blood loss in normotensive (control) sheep and in sheep with hypertensive CKD at 30 months after RDN (control-RDN, CKD-RDN) or sham (control-intact, CKD-intact) procedure. CKD-RDN sheep had lower basal blood pressure (BP; ≈9 mm Hg) and higher basal ren..

View full abstract

University of Melbourne Researchers